|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 326.30 DKK | +9.02% |
|
+0.43% | -30.04% |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Biological Products | ||||||||||
Biotechnology | 293M | 104M | 343M | 62.69M | 9.21B | |||||
Total Assets | 2.07B | 1.54B | 1.98B | 9.51B | 15.95B | |||||
Interest Expense | -4.09M | -57.79M | -25.83M | -34.05M | -29.06M | |||||
Income Tax Expense | -8.79M | -6.43M | -5.13M | -4.62M | 546M | |||||
CAPEX | -22.13M | -11.71M | -11.24M | -10.05M | -33.36M | |||||
EBT | -1.03B | -972M | -709M | -1.08B | 7B | |||||
Gross Profit | 174M | 104M | 324M | 54.82M | 9.21B | |||||
D&A | 40.25M | 102M | 20.12M | 23.12M | 24.01M | |||||
Operating Income | -1.05B | -837M | -572M | -1.27B | 6.96B | |||||
Net Income | -1.02B | -1.2B | -704M | -1.08B | 6.46B |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Switzerland | - | - | - | - | 9.18B | |||||
Denmark | - | 35M | 44.18M | 62.28M | 34.9M | |||||
Total Assets | 185M | 144M | 137M | 125M | 257M | |||||
United States | 240M | 69M | 4.09M | 406K | - | |||||
Total Assets | 107M | 21.7M | 13.03M | - | - | |||||
Germany | 53M | - | 295M | - | - | |||||
Foreign | - | - | - | - | - |
- Stock Market
- Equities
- ZEAL Stock
- Financials Zealand Pharma A/S
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
